About BioFlorida
BioFlorida is the voice of Florida’s life sciences industry, representing 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians. SOURCE
WELCOME TO OUR NEWEST MEMBERS (JANUARY-current)LEADERSHIP: Commissioning Agents, Inc. and JBK Associates International
PREFERRED: Goodwin Biotechnology, OrganaBio, LLC and Noven Pharmaceuticals
Core: AireHealth, Air-eze Scientific Services, Atlas Analytical, Botanica Testing, Cytonics Corporation, Deluge Biotechnologies, Evren Technologies, Golden Griffon, InSitu Biologics, LGM Pharma, Life Sciences Advanced Technologies, Sphere Fluidics and VuEssence Inc.
Supporting: 360 Life Sciences Advisors, BMKD, Feldman Bio, GForce Life Sciences, Harrington Pure, Hylant, JFK Communications, LabSense Technologies, Life Science Women's Conference, Miami International Airport, SCAD Media, WHK Biosystems
Important and timely updates ...
Get the key information you need from the links below:
- Early Bird Registration is Open for BioFlorida Conference
- On June 27 - Conversations with Women Leaders in the Life Sciences at UF Innovate | The Hub
- #BioFL19 Conference Sponsorship Opportunities - October 20-22 in Tampa
State Advocacy Updates:
End of Legislative Session Report, Budget Detail and Bill Tracker Now Available
Governor Ron DeSantis signed legislation to allow for the importation of prescription drugs from Canada and from other countries. The importation programs require approval from federal authorities. During the recently completed legislative session, BioFlorida educated policymakers about the practical implications of this proposal and emphasized the breadth of the current FDA regulatory environment. “The U.S. currently has a secure supply chain for prescription medicine, meaning the Food and Drug Administration (FDA) oversees every step in the development, production and distribution of all the treatments sold here. We look forward to working with Florida policy makers to improve drug affordability, while ensuring patient safety.” – Nancy Bryan, President & CEO, BioFlorida
A COMPANY RESOURCE GUIDE with 
